| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.04. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.04. | Purple Biotech Ltd.: Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting | 50 | GlobeNewswire (Europe) | Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- Purple... ► Artikel lesen | |
| 28.03. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 14.03. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 14.03. | Purple Biotech Ltd.: Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology | 354 | GlobeNewswire (Europe) | Contribution of NK cells engager arm and conditionally activated T cell engager demonstrated Cleavable capping technology confines therapeutic activity to the local tumor micro environment which... ► Artikel lesen | |
| 05.03. | PURPLE BIOTECH LTD. - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
| 05.03. | Purple Biotech Ltd.: Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results | 446 | GlobeNewswire (Europe) | REHOVOT, Israel, March 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness... ► Artikel lesen | |
| 05.03. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 27.02. | Purple Biotech Ltd.: Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024 | 341 | GlobeNewswire (Europe) | NT219 was well tolerated Anti-tumor activity at relevant higher dose levels observed with 29% Objective Response Rate (ORR) and 71% Disease Control Rate (DCR) REHOVOT, Israel, Feb. 27, 2024 (GLOBE... ► Artikel lesen | |
| 13.02. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.02. | Purple Biotech Ltd.: Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial | 1 | GlobeNewswire (USA) | ||
| 01.02. | Purple Biotech stock climbs 9% on Phase 2 study update | 3 | Seeking Alpha | ||
| 01.02. | Purple Biotech sets phase 2 dose for cancer drug NT219 | 2 | Investing.com | ||
| 01.02. | Purple Biotech Ltd.: Purple Biotech Reaches Recommended Phase 2 Dose for NT219 | 191 | GlobeNewswire (Europe) | REHOVOT, Israel, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness... ► Artikel lesen | |
| 26.01. | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.12.23 | Purple Biotech Ltd.: Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors | 1 | GlobeNewswire (USA) | ||
| 14.12.23 | PURPLE BIOTECH LTD. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.12.23 | Purple Biotech Ltd.: Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial | 479 | GlobeNewswire (Europe) | This acceleration of recruitment is expected to result in earlier look at overall survival of patients REHOVOT, Israel, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech"... ► Artikel lesen | |
| 21.11.23 | Purple Biotech: Q3 Earnings Insights | 2 | Benzinga.com |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 227 |
| BAYER | 203 |
| NEL | 192 |
| NVIDIA | 164 |
| TUI | 157 |
| SIEMENS ENERGY | 154 |
| RHEINMETALL | 139 |
| PLUG POWER | 133 |
| MERCEDES-BENZ | 128 |
| BYD | 123 |
| NOVAVAX | 116 |
| TESLA | 105 |
| DEUTSCHE BANK | 103 |
| PALANTIR TECHNOLOGIES | 102 |
| RWE | 98 |
| BASF | 88 |
| DEUTSCHE LUFTHANSA | 88 |
| ALLIANZ | 84 |
| VOLKSWAGEN | 82 |
| THYSSENKRUPP | 70 |
| COMMERZBANK | 69 |
| AMAZON | 63 |
| INFINEON | 62 |
| E.ON | 59 |
| NORDEX | 59 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
